ArticleJournal of thoracic disease2025
Perioperative changes in lung re-transplantation: a single-centre observational study.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Feasibility of anticoagulation-free peripheral veno-arterial extracorporeal membrane oxygenation in re-do lung transplantation.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Reports describing the management of lung re-transplantation (Re-LTx) are lacking. Therefore, this study evaluated the characteristics of Re-LTx to guide perioperative management. Methods: This study retrospectively analysed the clinical data of patients who underwent primary lung transplantation (primary-LTx) and Re-LTx in the First Affiliated Hospital of Guangzhou Medical University from 2016 to 2023. The key perioperative changes after Re-LTx (primary outcome) and the short-term postoperative rehabilitation characteristics (secondary outcome) were evaluated. Results: The study included 26 patients who underwent primary LTx who were propensity score-matched (1:2) with 13 patients who underwent Re-LTx. The preoperative Acute Physiology and Chronic Health Evaluation (APACHE) score was higher in the Re-LTx group (P=0.001). The intraoperative conditions, incidence of postoperative extracorporeal membrane oxygenation (ECMO) support, intensive care unit (ICU) stay, duration of postoperative hospital stay, total hospital stay, and complications on postoperative day seven did not differ between the groups (P>0.05). However, the intraoperative haemoglobin and fibrinogen levels were lower (P=0.002 and P=0.03, respectively), and the blood urea nitrogen and serum creatinine levels were higher in the Re-LTx group (both P<0.001). The pH, arterial oxygen pressure, partial pressure of carbon dioxide, and haemodynamic values did not differ between the groups (P>0.05). Conclusions: The perioperative management of Re-LTx may be similar to that of primary LTx based on comparable intraoperative conditions and postoperative rehabilitation characteristics. However, patients undergoing Re-LTx were prone to renal dysfunction and intraoperative anaemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.